OUR MISSION

Cancer is the second leading cause of death in the United States, killing more than 600,000 Americans and nearly 10 million people worldwide each year.

Many cancer indications have few, if any, treatment options available. The limited therapy options that do exist often have low success rates, especially for rare cancer types where research funding is scarce. At BreakBio, we have developed a platform for designing custom therapies to treat all solid tumors. We believe our platform can address this unmet need in rare cancers and provide substantial improvements over existing therapies for more common cancer types, increasing the likelihood that the FDA will grant us Breakthrough Therapy Designation.

Achieving a BREAKTHROUGH to help these patients survive longer, and hopefully be cured, is our mission.